[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avita Medical Inc (RCEL)

Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 323,159
  • Shares Outstanding, K 30,777
  • Annual Sales, $ 71,610 K
  • Annual Income, $ -48,590 K
  • EBIT $ -38 M
  • EBITDA $ -35 M
  • 60-Month Beta 1.86
  • Price/Sales 4.26
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 75.41% (+2.30%)
  • Historical Volatility 159.36%
  • IV Percentile 2%
  • IV Rank 1.10%
  • IV High 807.43% on 02/18/26
  • IV Low 67.24% on 08/19/26
  • Expected Move (DTE 23) 0.94 (9.03%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 202
  • Volume Avg (30-Day) 479
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 3,017
  • Open Int (30-Day) 2,176
  • Expected Range 9.42 to 11.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.46
  • Growth Rate Est. (year over year) +217,273.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.24 +145.35%
on 07/31/26
10.77 -3.30%
on 08/25/26
+5.80 (+125.92%)
since 07/24/26
3-Month
3.73 +179.36%
on 06/25/26
10.77 -3.30%
on 08/25/26
+6.16 (+145.06%)
since 05/26/26
52-Week
3.22 +223.45%
on 01/07/26
10.77 -3.30%
on 08/25/26
+5.86 (+128.40%)
since 08/26/25

Most Recent Stories

More News
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

VALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

VALENCIA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,”...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical to Announce Second Quarter 2026 Financial Results

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical to Announce Second Quarter 2026 Financial Results

AVITA Medical will report second quarter 2026 financial results after the close of the U.S. financial markets on Thursday, August 6, 2026. ...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

First U.K. case series demonstrates successful use of RECELL GO ® in 17 burn and reconstructive surgery patients Findings presented at the British Burn Association Annual Meeting support the role...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders...

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
AVITA Medical to Host Investor Webinar Briefing

AVITA Medical to host separate investor webinar and Melbourne Q&A event following Q1 2026 results and business updates....

AVH.AX : 2.910 (+6.20%)
RCEL : 10.64 (+1.33%)
Avita Medical Q1 Earnings Call Highlights

Avita Medical (NASDAQ:RCEL) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook as management said reimbursement conditions for its RECELL product are normalizing and demand...

RCEL : 10.64 (+1.33%)

Business Summary

AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.

See More

Key Turning Points

3rd Resistance Point 11.71
2nd Resistance Point 11.24
1st Resistance Point 10.87
Last Price 10.64
1st Support Level 10.03
2nd Support Level 9.56
3rd Support Level 9.19

See More

52-Week High 10.77
Last Price 10.64
Fibonacci 61.8% 7.89
Fibonacci 50% 7.00
Fibonacci 38.2% 6.10
52-Week Low 3.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.